The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sexually Transmitted Diseases (STD) Testing Market Research Report 2025
Synopsis
Sexually Transmitted Diseases (STD) Testing is used to detect all kinds of Sexually Transmitted virus.Sexually transmitted diseases are considered as one of the most critical health challenges globally. Chlamydia, gonorrhea, and herpes simplex virus are some of the highly prevalent sexually transmitted diseases.
The global Sexually Transmitted Diseases (STD) Testing market was valued at US$ 78450 million in 2023 and is anticipated to reach US$ 100680 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.
North American market for Sexually Transmitted Diseases (STD) Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sexually Transmitted Diseases (STD) Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Sexually Transmitted Diseases (STD) Testing in Laboratory Testing is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Sexually Transmitted Diseases (STD) Testing include ROCHE HOLDINGS, BIOMERIEUX, HOLOGIC, BECTON DICKINSON, ORASURE, DANAHER, AFFYMETRIX, ABBOTT LABORATORIES and BIO-RAD LABORATORIES, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sexually Transmitted Diseases (STD) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sexually Transmitted Diseases (STD) Testing.
Report Scope
The Sexually Transmitted Diseases (STD) Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sexually Transmitted Diseases (STD) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sexually Transmitted Diseases (STD) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ROCHE HOLDINGS
BIOMERIEUX
HOLOGIC
BECTON DICKINSON
ORASURE
DANAHER
AFFYMETRIX
ABBOTT LABORATORIES
BIO-RAD LABORATORIES
DIASORIN
Segment by Type
Chlamydia
Syphilis
Gonorrhea
Herpes Simplex Virus
Human Papilloma Virus
Human Immunodeficiency Virus
Others
Segment by Application
Laboratory Testing
Point of Care (POC) Testing
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sexually Transmitted Diseases (STD) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Sexually Transmitted Diseases (STD) Testing is used to detect all kinds of Sexually Transmitted virus.Sexually transmitted diseases are considered as one of the most critical health challenges globally. Chlamydia, gonorrhea, and herpes simplex virus are some of the highly prevalent sexually transmitted diseases.
The global Sexually Transmitted Diseases (STD) Testing market was valued at US$ 78450 million in 2023 and is anticipated to reach US$ 100680 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.
North American market for Sexually Transmitted Diseases (STD) Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sexually Transmitted Diseases (STD) Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Sexually Transmitted Diseases (STD) Testing in Laboratory Testing is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Sexually Transmitted Diseases (STD) Testing include ROCHE HOLDINGS, BIOMERIEUX, HOLOGIC, BECTON DICKINSON, ORASURE, DANAHER, AFFYMETRIX, ABBOTT LABORATORIES and BIO-RAD LABORATORIES, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sexually Transmitted Diseases (STD) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sexually Transmitted Diseases (STD) Testing.
Report Scope
The Sexually Transmitted Diseases (STD) Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sexually Transmitted Diseases (STD) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sexually Transmitted Diseases (STD) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ROCHE HOLDINGS
BIOMERIEUX
HOLOGIC
BECTON DICKINSON
ORASURE
DANAHER
AFFYMETRIX
ABBOTT LABORATORIES
BIO-RAD LABORATORIES
DIASORIN
Segment by Type
Chlamydia
Syphilis
Gonorrhea
Herpes Simplex Virus
Human Papilloma Virus
Human Immunodeficiency Virus
Others
Segment by Application
Laboratory Testing
Point of Care (POC) Testing
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sexually Transmitted Diseases (STD) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sexually Transmitted Diseases (STD) Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chlamydia
1.2.3 Syphilis
1.2.4 Gonorrhea
1.2.5 Herpes Simplex Virus
1.2.6 Human Papilloma Virus
1.2.7 Human Immunodeficiency Virus
1.2.8 Others
1.3 Market by Application
1.3.1 Global Sexually Transmitted Diseases (STD) Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Laboratory Testing
1.3.3 Point of Care (POC) Testing
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sexually Transmitted Diseases (STD) Testing Market Perspective (2019-2030)
2.2 Sexually Transmitted Diseases (STD) Testing Growth Trends by Region
2.2.1 Global Sexually Transmitted Diseases (STD) Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sexually Transmitted Diseases (STD) Testing Historic Market Size by Region (2019-2024)
2.2.3 Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Region (2025-2030)
2.3 Sexually Transmitted Diseases (STD) Testing Market Dynamics
2.3.1 Sexually Transmitted Diseases (STD) Testing Industry Trends
2.3.2 Sexually Transmitted Diseases (STD) Testing Market Drivers
2.3.3 Sexually Transmitted Diseases (STD) Testing Market Challenges
2.3.4 Sexually Transmitted Diseases (STD) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sexually Transmitted Diseases (STD) Testing Players by Revenue
3.1.1 Global Top Sexually Transmitted Diseases (STD) Testing Players by Revenue (2019-2024)
3.1.2 Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share by Players (2019-2024)
3.2 Global Sexually Transmitted Diseases (STD) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sexually Transmitted Diseases (STD) Testing Revenue
3.4 Global Sexually Transmitted Diseases (STD) Testing Market Concentration Ratio
3.4.1 Global Sexually Transmitted Diseases (STD) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Diseases (STD) Testing Revenue in 2023
3.5 Sexually Transmitted Diseases (STD) Testing Key Players Head office and Area Served
3.6 Key Players Sexually Transmitted Diseases (STD) Testing Product Solution and Service
3.7 Date of Enter into Sexually Transmitted Diseases (STD) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sexually Transmitted Diseases (STD) Testing Breakdown Data by Type
4.1 Global Sexually Transmitted Diseases (STD) Testing Historic Market Size by Type (2019-2024)
4.2 Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Type (2025-2030)
5 Sexually Transmitted Diseases (STD) Testing Breakdown Data by Application
5.1 Global Sexually Transmitted Diseases (STD) Testing Historic Market Size by Application (2019-2024)
5.2 Global Sexually Transmitted Diseases (STD) Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sexually Transmitted Diseases (STD) Testing Market Size (2019-2030)
6.2 North America Sexually Transmitted Diseases (STD) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2019-2024)
6.4 North America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sexually Transmitted Diseases (STD) Testing Market Size (2019-2030)
7.2 Europe Sexually Transmitted Diseases (STD) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2019-2024)
7.4 Europe Sexually Transmitted Diseases (STD) Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size (2019-2030)
8.2 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sexually Transmitted Diseases (STD) Testing Market Size (2019-2030)
9.2 Latin America Sexually Transmitted Diseases (STD) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2019-2024)
9.4 Latin America Sexually Transmitted Diseases (STD) Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size (2019-2030)
10.2 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Sexually Transmitted Diseases (STD) Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ROCHE HOLDINGS
11.1.1 ROCHE HOLDINGS Company Detail
11.1.2 ROCHE HOLDINGS Business Overview
11.1.3 ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Introduction
11.1.4 ROCHE HOLDINGS Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
11.1.5 ROCHE HOLDINGS Recent Development
11.2 BIOMERIEUX
11.2.1 BIOMERIEUX Company Detail
11.2.2 BIOMERIEUX Business Overview
11.2.3 BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Introduction
11.2.4 BIOMERIEUX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
11.2.5 BIOMERIEUX Recent Development
11.3 HOLOGIC
11.3.1 HOLOGIC Company Detail
11.3.2 HOLOGIC Business Overview
11.3.3 HOLOGIC Sexually Transmitted Diseases (STD) Testing Introduction
11.3.4 HOLOGIC Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
11.3.5 HOLOGIC Recent Development
11.4 BECTON DICKINSON
11.4.1 BECTON DICKINSON Company Detail
11.4.2 BECTON DICKINSON Business Overview
11.4.3 BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Introduction
11.4.4 BECTON DICKINSON Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
11.4.5 BECTON DICKINSON Recent Development
11.5 ORASURE
11.5.1 ORASURE Company Detail
11.5.2 ORASURE Business Overview
11.5.3 ORASURE Sexually Transmitted Diseases (STD) Testing Introduction
11.5.4 ORASURE Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
11.5.5 ORASURE Recent Development
11.6 DANAHER
11.6.1 DANAHER Company Detail
11.6.2 DANAHER Business Overview
11.6.3 DANAHER Sexually Transmitted Diseases (STD) Testing Introduction
11.6.4 DANAHER Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
11.6.5 DANAHER Recent Development
11.7 AFFYMETRIX
11.7.1 AFFYMETRIX Company Detail
11.7.2 AFFYMETRIX Business Overview
11.7.3 AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Introduction
11.7.4 AFFYMETRIX Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
11.7.5 AFFYMETRIX Recent Development
11.8 ABBOTT LABORATORIES
11.8.1 ABBOTT LABORATORIES Company Detail
11.8.2 ABBOTT LABORATORIES Business Overview
11.8.3 ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Introduction
11.8.4 ABBOTT LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
11.8.5 ABBOTT LABORATORIES Recent Development
11.9 BIO-RAD LABORATORIES
11.9.1 BIO-RAD LABORATORIES Company Detail
11.9.2 BIO-RAD LABORATORIES Business Overview
11.9.3 BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Introduction
11.9.4 BIO-RAD LABORATORIES Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
11.9.5 BIO-RAD LABORATORIES Recent Development
11.10 DIASORIN
11.10.1 DIASORIN Company Detail
11.10.2 DIASORIN Business Overview
11.10.3 DIASORIN Sexually Transmitted Diseases (STD) Testing Introduction
11.10.4 DIASORIN Revenue in Sexually Transmitted Diseases (STD) Testing Business (2019-2024)
11.10.5 DIASORIN Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
